- Antibodies
- New
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Tag
- Peptides
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Amino Acids
- Tag
- Biological Process >
- Proteins
- RNAi
- FL cDNA Clones
- Cell/Tissues/Lysates
Vimentin AntibodyRabbit Monoclonal Antibody
| Country | United States
Ordering Information
|
|||
|---|---|---|---|---|
| Catalog # | Size | Availability | Price | |
| AJ1815b | 100ul 400 ul | 2-3 days | $ 275.00 | DISCONTINED INQUIRE CLICK INQUIRE Add to cart |
- Specification
- Citiations : 0
- Reviews
- Protocols
- Backgrounds
Vimentin Antibody - Product info | |
| Application | IHC
|
| Primary Accession | P08670 |
| Reactivity | Human |
| Clone Names | SP20 |
| Calculated MW | 53652 Da |
| Gene ID 7431 | |
| Other Names VIM, Vimentin | |
| Target/Specificity A recombinant human vimentin protein. | |
| Dilution IHC~~1:200~400 | |
| Format 50 mM Tris-Glycine (pH 7.4), 0.15 M NaCl, 40% Glycerol, 0.01% sodium azide and 0.05% BSA. | |
| Storage Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. | |
| Precautions Vimentin Antibody is for research use only and not for use in diagnostic or therapeutic procedures. | |
Vimentin Antibody - Protein Information | |
| Name VIM | |
| Function Vimentins are class-III intermediate filaments found in various non-epithelial cells, especially mesenchymal cells Vimentin is attached to the nucleus, endoplasmic reticulum, and mitochondria, either laterally or terminally | |
| Cellular Location Cytoplasm. | |
| Tissue Location Highly expressed in fibroblasts, some expression in T- and B-lymphocytes, and little or no expression in Burkitt's lymphoma cell lines. Expressed in many hormone- independent mammary carcinoma cell lines | |
Vimentin Antibody - Related products
AP11553c: PTGS2 Antibody (Center P378)
AP2739a: Vimentin Antibody (S82)
AP2739b: Vimentin Antibody (C-term)
AP2739c: Vimentin Antibody (Center)
AP3546a: Phospho-Vimentin-S82 Antibody
BP2739a: Vimentin Antibody (S82) Blocking Peptide
BP2739b: Vimentin Antibody (C-term) Blocking Peptide
BP2739c: Vimentin Antibody (Center) Blocking Peptide
BP3546a: Phospho-Vimentin-S82 Antibody Blocking Peptide
AJ1815c: Vimentin Antibody Phospho (pS38)
AJ1815d: Vimentin Antibody Phospho (pS72)
Vimentin Antibody - Application data
-
A. Immunohistochemical staining of paraffin-embedded Human melanoma stained with anti-Vimentin RabMAb (Cat. #AJ1815b)
Vimentin Antibody - Research Areas
Abgent welcomes feedback from its customers.
If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abgent.com.
Thank you for your support.
Provided below are standard protocols that you may find useful for product applications.
BACKGROUND
Vimentin is the most common member of intermediate filament (IF) family and one of the main components in cytoskeleton structure. It is expressed during cell development and differentiation in a variety of mesenchymal cells and cell types derived from mesoderm (1). Vimentin is essential in the role of cell integrity and cytoskeletal stability. The reorganization of Vimentin, similar to all IF proteins, occurs during different stages of the cell cycle and cell signaling by a site-specific phosphorylation (serine and threonine residues) (2). In particular, p21-activated kinase (PAK) phosphorylates at Ser25, Ser38, Ser50, Ser65 and Ser72 which induces Vimentin-specific reorganization (3). During cytokinesis, Vimentin is regulated by Rho-kinase (ROCK) and Aurora B through phosphorylation at Ser38 and Ser72 (4).
REFERENCES
1. Eriksson JE et al. Curr. Opin. Cell Biol. 4:99-104, 1992.
2. Inagaki M et al. Nature 328: 649-652, 1987.
3. Goto H et al. GENES CELLS 7:91-97. 2002.
4. Goto H et al. J Biol Chem, 273(19):11728-11736, 1998.